Trinity Biotech plc Gains 36.07%
Tue, Jul 28, 2026 at 07:39 PM
Trinity Biotech plc (TRIB:NASDAQ) rocketted at $12.45, representing a gain of 36.1%. On Tue, Jul 28, 2026, TRIB:NASDAQ touched a New 2-Week High of $12.45. The stock appeared on our News Catalysts scanner on Wed, Jul 22, 2026 at 08:56 AM in the 'PATNERSHIP' category. From Tue, Jul 14, 2026, the stock recorded 60.00% Up Days and 45.45% Green Days
About Trinity Biotech plc (TRIB:NASDAQ)
Trinity Biotech PLC develops, manufactures and markets clinical diagnostic products. Its products are used for detecting autoimmune, sexually transmitted diseases, diabetes and disorders of the liver.
Top 10 Gainers:
- Steakholder Foods Ltd. (STKH:NASDAQ), 166.67%
- Enigmatig Limited Class A (EGG:NYSEMKT), 85.85%
- T3 Defense Inc Com New (DFNS:NASDAQ), 83.21%
- C3is Inc. (CISS:NASDAQ), 63.09%
- INLIF Limited (INLF:NASDAQ), 61.59%
- Baiya International Group Inc. (BIYA:NASDAQ), 54.44%
- ZW Data Action Technologies Inc. (CNET:NASDAQ), 41%
- Trinity Biotech plc (TRIB:NASDAQ), 36.07%
- Nexera Technologies Ltd Ord Shs (NEXR:NASDAQ), 33.69%
- OPKO Health, Inc. (OPK:NASDAQ), 33.06%